Probiotic composition containing Lactobacillus casei strain ATCC PTA-3945
AssigneeProbioHealth, LLC
InventorA. Satyanarayan Naidu
Life of this patent
Estimating the term…
Abstract
Probiotic compositions are provided that comprise Lactobacillus casei strain KE01 having ATCC accession number PTA-3945. The disclosed probiotic compositions are useful in inhibiting enteric pathogen diseases in animals and in maintaining animal health. Methods of making and using Lactobacillus casei strain KE01 probiotic compositions are also disclosed as are methods of using these probiotic compositions.
Claims33
A probiotic composition comprising biologically pure culture of Lactobacillus casei strain KE01 having ATCC accession number PTA-3945, Lactobacillus casei strain KE01 is derived from a biologically pure culture.
The probiotic composition according to clam 13 wherein said Lactobacilli casei strain KE01 is present in the amount of approximately 105 to 1011 colony forming units (CFU) per gram.
A probiotic composition comprising:
- powdered Lactobacillus casei strain KE01 having ATCC accession number PTA-3945 in the amount of from approximately 1 to 5 weight percent;
- a disaccharide form approximately 25 to 95 weight percent;
- an oligosaccharide from approximately 0 to 10 weight percent;
- and
- a polysaccharide from approximately 0 to 50 weight percent.
A probiotic composition comprising:
- approximately 3 weight percent of powdered Lactobacillus casei strain KE01 having ATCC accession number PTA-3945 having approximately 105 to 1011 CFU per gram;
- approximately 62 weight percent trehalose;
- approximately 5 weight percent fructo-oligosaccharide;
- and
- approximately 30 weight percent malt dextrin.
Dependencies are inferred from the claim text.